Gycoprotein D (gD) is a glycoprotein expressed on the surface of several human and animal alpha herpes viruses. Binding of gD to cellsurface receptors has been shown to be necessary for herpes simplex virus 1 and 2 (HSV-1 and HSV-2) cell entry. The gD ectodomain consists of 316 residues and has no sequence homology to any other proteins of known structure. Two fragments of the HSV-1 gD ectodomain (gD 22±260 : residues 22±260 and gD 285 : residues 1±285) have been crystallized in two crystal forms. The complex between gD 285 and the ectodomain of HveA, a gD cellular receptor member of the tumor necrosis factor (TNFR) superfamily, has also been crystallized. Moreover, insect-cell-expressed selenomethioninesubstituted gD 285 has been puri®ed and crystallized alone and in complex with HveA.
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Introduction
Alpha herpes viruses are large doublestranded DNA viruses that infect humans [herpes simplex virus 1 and 2 (HSV-1 and HSV-2)] and animals [e.g. bovine herpes virus 1 (BHV-1) and porcine pseudorabies virus (PrV)]. HSV-1 and HSV-2 are widespread in the human population: HSV-1 is normally associated with oral and ocular lesions, whereas HSV-2 is isolated primarily from genital and oral lesions. After an initial infection in epithelial cells, the virus spreads to host neuronal cells where it can remain latent for life (Roizman & Sears, 1987) . The mechanism of infection of this family of viruses is complex and not fully understood. At least ®ve glycoproteins (gB, gC, gD and the gH/gL complex) on the virion envelope are involved in HSV cell entry (reviewed in Spear et al., 2000) . Among those, glycoprotein D (gD) has been shown to mediate binding to cellular receptors (reviewed in Campadelli-Fiume et al., 2000; Spear et al., 2000) .
HSV-1 gD is a 369-residue glycoprotein with an N-terminal ectodomain of 316 residues and three N-linked oligosaccharide-attachment sites (Watson et al., 1982) . The protein has six cysteine residues which form three disul®de bonds (Long et al., 1992 ; HSV-1 and HSV-2 gD ectodomains have 85% sequence identity) and ®ve methionines. In the past three years, several gD receptors have been identi®ed (Campadelli-Fiume et al., 2000; Spear et al., 2000) . The ®rst receptor to be cloned was HveA, a member of the TNFR/NGFR superfamily expressed on the surface of activated T-lymphocytes, where it mediates HSV-1 and HSV-2 entry (Montgomery et al., 1996) .
HveA (also called HVEM or TNFRSF14) is a type I membrane protein with an ectodomain of 162 residues and two N-linked oligosaccharide-attachment sites. Sequence alignments show that the ®rst N-terminal 100 residues have a signi®cant sequence identity (close to 30%) with the TNFR family member TNFR-1, whose structure is known (Banner et al., 1993; Naismith et al., 1996) . gD is an important target for antiviral agents and soluble forms of gD are in clinical trials as vaccines against HSV-1 and HSV-2. To gain insights into the role of gD in HSV entry, we have started structural studies on gD (Krummenacher et al., 1998; Whitbeck et al., 1997; Willis et al., 1998) and on complexes of gD with cellular receptors. Here, we report the crystallization and preliminary diffraction data of a recombinant gD ectodomain alone and in complex with the ectodomain of HveA.
Material and methods
2.1. Protein purification, preparation of selenomethionine-substituted gD 285 and gD 285 ±HveA complex reconstitution Both the HveA ectodomain (residues 1±162 plus a C-terminal His 5 tag) and two soluble C-terminally truncated forms of gD (residues 1±306 and 1±285) were puri®ed from Sf9 insect-cell culture supernatants (Sisk et al., 1994) . HveA was puri®ed on an Ni 2+ -resin followed by size-exclusion chromatography on a Pharmacia analytical Superdex-200 column. gD 285 and gD 306 were puri®ed using DL6-antibody af®nity chromatography with pH 11 elution (DL-6 recognizes a linear epitope, crystallization papers residues 272±279, near the C-terminus of gD; Isola et al., 1989) followed by ion exchange on a MonoQ column (Pharmacia) and size-exclusion chromatography on an analytical Superdex-200 column (Pharmacia). Selenomethionine-substituted gD 285 was produced following published protocols (for a review, see Bellizzi et al., 1999) that were slightly modi®ed. Sf9 cells were grown to a density of 10 6 cells ml À1 in 1 l spinner asks in methionine-containing Sf9-II00 media (GIBCO) (500 ml). 24 h post-infection, the cells were gently spun down and moved to methionine-free Grace's media (GIBCO) to remove the intracellular pull of methionine. 12±14 h later the cells were transferred to a fresh methionine-free Grace's media supplemented with 5% dialyzed fetal bovine serum (FBS; Sigma) and 75 mg ml À1 selenomethione (Sigma) for an additional 48 h. The protein was then puri®ed from the Sf9 insect-cell culture supernatants by the same methods as the native protein.
The yield for the selenomethionine protein was approximately 50±60% compared with that normally achieved in a native protein preparation. Amino-acid analysis showed that 85% selenomethionine incorporation had been obtained.
The gD 285 ±HveA complex was prepared by titration of gD 285 with increasing amounts of HveA, observing the gel shift with native PAGE (without SDS or -mercaptoethanol). The complex was then puri®ed by size-exclusion chromatography on an analytical Superdex-200 column, which allowed separation of the complex from the excess unbound gD.
Crystallization
Preliminary crystallization trials were performed by the hanging-drop vapour-diffusion method. Typically, 1 ml of protein solution (5.5±12 mg ml À1 in 10 mM Tris±HCl pH 7.0 and 100 mM NaCl) was mixed with an equal volume of well solution. Once crystals were obtained, crystal growth was optimized using the sitting-drop method with larger protein droplets.
We ®rst tried to crystallize gD 306 . Small crystals (approximately 0.15±0.2 mm per side; Fig. 1b ) grow in about three months in droplets equilibrated with solutions containing 50 mM MES pH 6.0 as buffer and 1.6 M ammonium sulfate as precipitating agent. SDS gels of washed crystals showed that the protein had been partially proteolysed during the long crystallization period. N-terminal sequencing showed that the crystals contained a gD core starting at residue 21 of the mature protein and this information together with MALDI mass spectrometry indicates that the new C-terminus is in the proximity of residue 260.
Crystals of gD 285 or Se-Met gD 285 were obtained in the pH range 6.0±9.0 using 1.4 M ammonium sulfate as precipitating agent. The largest crystals (0.6 Â 0.3 Â 0.3 mm) (Fig. 1a) were grown by mixing 3 ml of puri®ed complex solution with an equal volume of a reservoir solution containing 50 mM Bicine pH 9.0 (or 50 mM MES pH 6.0) as buffer and 1.6 M ammonium sulfate as precipitating agent in sitting-drop experiments. SDS gels and N-terminal sequencing on washed crystals con®rmed the presence of the full protein (residues 1±285) in the crystals.
More recently, crystals of the gD 285 ± HveA and SeMet gD 285 ±HveA complexes have been obtained (Fig. 1c) . The complex was prepared by titrating gD285 with increasing amounts of HveA162 and observing the gel shift with native PAGE and was further puri®ed by size-exclusion chromatography on a Superdex-200 column. Large crystals (0.8 Â 0.3 Â 0.2 mm) were obtained in sitting-drop experiments by mixing 3 ml of puri®ed complex solution with an equal volume of a reservoir solution containing 50 mM Tris±HCl pH 8.0 as buffer and 1.8 M ammonium sulfate and 5% PEG 400 as precipitating agents. Figure 2 w = 0.4 section in the gD 285 native Patterson map (0 < u < 1 and 0 < v < 1). The peak at u = 0.5, v = 0.5 in this section has half the intensity of the origin peak.
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Results and discussion
For X-ray data collection at cryogenic temperature, crystals were transferred stepwise to cryoprotectant solutions containing 20% glycerol (gD 285 and gD 22±260 ) or 20% ethylene glycol (gD 285 ±HveA) in crystallization buffer and¯ash-cooled at 100 K in N 2 gas. Preliminary characterization of the crystals was carried out in the laboratory on a MAR 30 cm detector mounted on a GX-13 X-ray generator with Charles Supper double focusing mirrors. Owing to the small size of gD 22±260 crystals and to the weak diffraction proprieties of the gD 285 and gD 285 ±HveA crystals, synchrotron X-ray sources had to be used for data collection ( Table 1 ). The HKL suite was used for data integration and scaling (Otwinoski & Minor, 1997) . The CCP4 suite was used for further data processing and analysis (Collaborative Computational Project, Number 4, 1994) . A 2.80 A Ê data set from gD 22±260 crystals was collected at the BIOCARS 14BMC beamline at the APS on a Q4-CCD detector and at 1.00 A Ê wavelength. The crystals belong to the space group P4 2 2 1 2 (Table 1) , with unit-cell parameters a = b = 158.67, c = 155.70 A Ê and at least four molecules in the asymmetric unit (V M = 3.8, corresponding to 67% solvent).
In the case of gD 285 , several crystals were screened. A 2.85 A Ê native data set was collected at the X25 beamline at BNL-NSLS on a Brandeis B4-CCD detector at 0.9754 A Ê wavelength. The data were indexed and integrated in the tetragonal space group P422, with unit-cell parameters a = b = 131.43, c = 83.27 A Ê (Table 1) . The diffraction images were characterized by the presence of streaked re¯ections in the b* and a* directions and also by the absence of many predicted re¯ections. A native Patterson map contained a peak with half the intensity of the origin peak at u = 0.5, v = 0.5 and w = 0.4 (Fig. 2) , which indicates the presence of two molecules in the asymmetric unit (V M = 2.75 A Ê 3 Da
À1
) related by translational non-crystallographic symmetry. The presence of streaked re¯ections in the diffraction pattern might be indicative of static disorder in the crystals.
For the gD 285 ±HveA crystals, a 2.65 A Ê resolution native data has been collected at the A1 beamline at CHESS on a Q4 CCD detector ( Table 1 ). The data were indexed and integrated in the P3 1 21 space group, with unit-cell parameters a = b = 129.15, c = 80.94 A Ê , and presumably contain one complex molecule per asymmetric unit (V M = 3.7 A Ê 3 Da À1 , corresponding to 67% solvent if we assume a 1:1 complex).
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